Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA)
- Status
- TERMINATED
- Phase
- PHASE2
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
- Status
- COMPLETED
- Phase
- PHASE3
Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
The BEACON Study (Breast Cancer Outcomes With NKTR-102)
- Status
- COMPLETED
- Phase
- PHASE3
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2